Manulife (Manufacturers Life Insurance)
XERS icon

Manulife (Manufacturers Life Insurance)’s Xeris Biopharma Holdings XERS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$422K Buy
72,804
+27,003
+59% +$179K ﹤0.01% 2232
2025
Q4 		$360K Sell
45,801
-4,343
-9% -$34.2K ﹤0.01% 2302
2025
Q3 		$408K Sell
50,144
-4,328
-8% -$28.8K ﹤0.01% 2287
2025
Q2 		$254K Buy
54,472
+3,562
+7% +$16.3K ﹤0.01% 2449
2025
Q1 		$279K Sell
50,910
-2,143
-4% -$8.65K ﹤0.01% 2365
2024
Q4 		$180K Sell
53,053
-3,090
-6% -$9.94K ﹤0.01% 2664
2024
Q3 		$160K Sell
56,143
-1,662
-3% -$4.27K ﹤0.01% 2743
2024
Q2 		$130K Buy
57,805
+5,291
+10% +$10.7K ﹤0.01% 2751
2024
Q1 		$116K Sell
52,514
-3,228
-6% -$8.35K ﹤0.01% 2745
2023
Q4 		$131K Hold
55,742
– – ﹤0.01% 2744
2023
Q3 		$104K Hold
55,742
– – ﹤0.01% 2795
2023
Q2 		$146K Sell
55,742
-546
-1% -$1.39K ﹤0.01% 2724
2023
Q1 		$91.7K Hold
56,288
– – ﹤0.01% 2764
2022
Q4 		$74.9K Buy
56,288
+1,161
+2% +$1.64K ﹤0.01% 2860
2022
Q3 		$86K Sell
55,127
-2,235
-4% -$3.7K ﹤0.01% 2850
2022
Q2 		$88.3K Buy
+57,362
New +$121K ﹤0.01% 2948
2021
Q2 		– Sell
-29,961
Closed -$135K – 3303
2021
Q1 		$135K Buy
29,961
+267
+0.9% +$1.44K ﹤0.01% 3008
2020
Q4 		$146K Buy
29,694
+2,862
+11% +$14.3K ﹤0.01% 2873
2020
Q3 		$159K Buy
+26,832
New +$107K ﹤0.01% 2654
2020
Q1 		– Sell
-17,351
Closed -$122K – 2910
2019
Q4 		$122K Sell
17,351
-1,145
-6% -$9.45K ﹤0.01% 2746
2019
Q3 		$178K Buy
18,496
+624
+3% +$7.01K ﹤0.01% 2647
2019
Q2 		$204K Buy
+17,872
New +$188K ﹤0.01% 2642

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s XERS Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Xeris Biopharma Holdings (XERS) stake by 59% in Q1 2026, buying an estimated $179K and bringing the position to 72,804 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Manulife (Manufacturers Life Insurance) first reported a position in XERS in Q2 2019 and has held it in 22 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 72,804 shares of Xeris Biopharma Holdings worth $422K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 27,003 Xeris Biopharma Holdings shares in Q1 2026, an estimated $179K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2232 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Xeris Biopharma Holdings in Q2 2019 and has held it in 22 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.